Lataa...
Patient-derived xenograft (PDX) tumors increase growth rate with time
Patient-derived xenograft (PDX) models are frequently used for translational cancer research, and are assumed to behave consistently as the tumor ages. However, growth rate constancy as a function of time is unclear. Notably, variable PDX growth rates over time might have implications for the interp...
Tallennettuna:
| Julkaisussa: | Oncotarget |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Impact Journals LLC
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4884970/ https://ncbi.nlm.nih.gov/pubmed/26783960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6919 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|